VALN
#2868
Valneva SE - American Depositary Shares
5.5 6 USD
-0.06%
Marktpreis
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-6.24%
Monatliche Änderung
-15.76%
6 month change
-11.32%
Jahresänderung
-46.33%
Vorheriger Schlusskurs
5.9 3
Eröffnungskurs
5.7 5
Tief
5.5 5
Hoch
5.8 0
Finanzen
- Market Capitalization 482.44 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry Biotechnologie
Verwandte Ticker
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2849 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.98 USD | -9.32% | -7.75% | -26.18% | +5.98% | 496.03 M USD | ||
| 2866 |  MNPR Monopar Therapeutics Inc. - Common Stock | 72.08 USD | -6.45% | -7.92% | -31.35% | +31.97% | 483.81 M USD | ||
| 2875 |  RGNX REGENXBIO Inc. - Common Stock | 7.26 USD | -6.56% | -0.68% | -16.46% | -45.94% | 479.26 M USD | ||
| 2880 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.57 USD | -5.99% | +0.64% | -13.26% | -24.52% | 474.65 M USD |